April 3, 2019
Patrick Soon-Shiong (photo by Ringo H.W. Chiu)
Stories this photo appears in:
Culver City-based ImmunityBio’s Covid-19 vaccine candidate drug has been approved to begin Phase 1 clinical trial testing.
A Los Angeles jury awarded $15.5 million to T.J. Simers in the journalist’s long-running age-discrimination lawsuit against the Los Angeles Times, but new Times owner Patrick Soon-Shiong will pay none of it.
A San Diego biotech firm alleged Patrick Soon-Shiong and his NantCell Inc. company implemented a “catch and kill” scheme to stymie a new cancer drug that could hurt sales of a rival blockbuster drug invented by the Los Angeles billionaire, according to a lawsuit filed April 3.